SARS CoV 2 News and Research

RSS

COVID-19 recovery disparities uncovered among racial and ethnic groups

Study reveals ethnic and racial disparities in health outcomes post-COVID-19 infection, with Hispanic and racial minority groups reporting poorer health status and increased work absence compared to their non-Hispanic and White counterparts.

4 Feb 2024

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Early estimates show the 2023-24 updated monovalent XBB.1.5 COVID-19 vaccine offers significant protection against symptomatic infection, with effectiveness varying by age and time since vaccination.

4 Feb 2024

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

First boosters, second boosters, monovalent, bivalent. Just like the SARS-CoV-2 virus strain, the vaccines to combat the virus are always changing—and perhaps confusing.

2 Feb 2024

BIPOC individuals infected with COVID-19 experienced greater negative aftereffects in health

Black, indigenous, and people of color (BIPOC) who were infected with COVID-19 experienced greater negative aftereffects in health and work loss than did similarly infected white participants, new research finds.

1 Feb 2024

New sequencing tool speeds up SARS-CoV-2 outbreak response and informs treatment

Announcing a new article publication for Zoonoses journal. In the context of two Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) outbreaks involving local transmission and an international flight, the authors of this article used meta-transcriptome and multi-amplicon sequencing to successfully acquire the complete viral genome sequences from clinical samples with varying viral loads.

1 Feb 2024

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

study identifies risk factors for prolonged SARS-CoV-2 infection in immunocompromised patients, revealing that B-cell dysfunction, solid organ transplantation, and AIDS lead to longer infections and unique spike mutations.

31 Jan 2024

Gut microbiome may hold key to fighting common respiratory viruses

The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

30 Jan 2024

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

30 Jan 2024

Resin ingredient strongly decreases coronavirus infectivity on plastic surfaces

Researchers at the University of Jyväskylä, Finland, are currently developing anti-viral surfaces to decrease the spread of infectious diseases.

30 Jan 2024

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

There are many lingering mysteries from the COVID-19 pandemic. For instance, why does SARS-CoV-2, the virus behind the disease, cause severe symptoms in some patients, while many other coronaviruses don't? And what causes strange symptoms to persist even after the infection has been cleared from a person's system?

30 Jan 2024

Over half of long COVID patients suffer persistent cognitive slowing, new study reveals

Study finds that 53% of long COVID patients experience significant cognitive slowing, a symptom that does not improve over time and is independent of the severity of the initial SARS-CoV-2 infection.

29 Jan 2024

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Researchers found that neonates born to mothers with SARS-CoV-2 infection face an increased risk of respiratory distress, potentially due to an inflammatory response triggered by prenatal exposure.

29 Jan 2024

New scientific statement outlines recommendations for diagnosing, managing cerebral venous thrombosis

A new scientific statement from the American Heart Association emphasizes the need to increase patients' and physicians' awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate prompt medical treatment.

29 Jan 2024

How does the nasal cavity's immune system combat SARS-CoV-2?

Researchers discovered that CD4+ and CD8+ T cells play a crucial role in clearing COVID-19 infection in the nasal cavity but have limited impact on lung infections, with implications for understanding and treating the virus.

28 Jan 2024

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Scientists at La Jolla Institute for Immunology (LJI) have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. In fact, prior exposure to a common cold coronavirus appears to partially protect mice from lung damage during a subsequent SARS-CoV-2 infection.

27 Jan 2024

SARS CoV 2 News and Research

COVID-19 recovery disparities uncovered among racial and ethnic groups

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

BIPOC individuals infected with COVID-19 experienced greater negative aftereffects in health

New sequencing tool speeds up SARS-CoV-2 outbreak response and informs treatment

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

Gut microbiome may hold key to fighting common respiratory viruses

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Resin ingredient strongly decreases coronavirus infectivity on plastic surfaces

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

Over half of long COVID patients suffer persistent cognitive slowing, new study reveals

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

New scientific statement outlines recommendations for diagnosing, managing cerebral venous thrombosis

How does the nasal cavity's immune system combat SARS-CoV-2?

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Europe gears up for future pandemics with AI-powered "PAIR" project

Study offers insights into who's at risk for long COVID among immunocompromised patients

The association between handgrip strength and functional outcomes in long COVID-19

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

Researchers discover "protective switches" that shield the coronavirus from immune system attacks

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News